Attends completes successful recapitalization: KPS

KPS Capital Partners, LP ("KPS") announced today that its portfolio company Attends Healthcare, Inc. ("Attends") has completed a successful recapitalization.  Attends raised $98 million of new financing, including a $20 million asset-based revolving credit facility and $78 million in term loans.  Proceeds of the recapitalization were used to refinance outstanding debt, to fund a $60 million cash distribution to stockholders and to fund the Company's continued growth.

Following the recapitalization, Attends remains conservatively capitalized with the continued support of KPS, its majority shareholder, a private equity firm with over $2.6 billion of committed capital.  KPS and Attends management continue to own 100% of Attends' common stock following the recapitalization.

The asset-based revolving credit facility was provided by Wells Fargo Capital Finance, and the term loan financing was provided by Regiment Capital Special Situations Fund IV, L.P.  Lincoln International acted as exclusive financial advisor to the Company and privately placed the financing.

K&L Gates LLP served as legal counsel to Attends with respect to the recapitalization.

SOURCE KPS Capital Partners, LP

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New center established to bridge AI technology and healthcare applications